Filter paper collection of plasma for IGF-I test in patients with acromegaly (original) (raw)

Comparative study of insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 (IGFBP-3) level and ratio measurements and their relationship with an index of clinical activity in the management of patients with acromegaly

R. García-mayor

Metabolism, 1997

View PDFchevron_right

Serum IGF-I measured by four different immunoassays in patients with adult GH deficiency or acromegaly and in a control population

Antonio Picó

Clinical Endocrinology, 2008

View PDFchevron_right

Biochemical markers of acromegaly: GH vs. IGF-I

Ariel Barkan

Growth Hormone & IGF Research, 2004

View PDFchevron_right

Plasma Insulin-Like Growth Factor-I/Somatomedin-C in Acromegaly: Correlation With the Degree of Growth Hormone Hypersecretion*

Ariel Barkan

The Journal of Clinical Endocrinology & Metabolism, 1988

View PDFchevron_right

Total and free insulin-like growth factor I, insulin-like growth factor binding protein 3 and acid-labile subunit reflect clinical activity in acromegaly

Ulla Feldt-rasmussen

Growth Hormone & IGF Research, 2001

View PDFchevron_right

Insulin-like growth factor I and daily growth hormone profile in the assessment of active acromegaly

Enrica Ciccarelli

Acta Endocrinologica, 1989

View PDFchevron_right

Measurement of salivary insulin-like growth factor-I in acromegaly: comparison with serum insulin-like growth factor-I and growth hormone concentrations

M. Korsić

Clinical Chemistry …, 1994

View PDFchevron_right

Insulin Like Growth Factor Binding Protein 7 as a Novel Diagnostic Marker in Sera of Iraqi Patients with Acromegaly

esam noori

Baghdad Science Journal, 2023

View PDFchevron_right

The Relationship between 24-Hour Growth Hormone Secretion and Insulin-Like Growth Factor I in Patients with Successfully Treated Acromegaly: Impact of Surgery or Radiotherapy

Stephen Shalet

The Journal of Clinical Endocrinology & Metabolism, 2001

View PDFchevron_right

IGF-1 levels across the spectrum of normal to elevated in acromegaly: relationship to insulin sensitivity, markers of cardiovascular risk and body composition

Jean Claude Patilla Fernandez

Pituitary, 2015

View PDFchevron_right

Diagnostic utility of serum GH, IGF-1 and IGFBP3 in patients of acromegaly with uncontrolled diabetes: a pilot study

Naresh Sachdeva

The Journal of the Association of Physicians of India, 2014

View PDFchevron_right

Insulin-like growth factor 1 measurement in diagnosis and management of acromegaly

Stephen Shalet

Annals of Clinical Biochemistry: International Journal of Laboratory Medicine, 2001

View PDFchevron_right

Pituitary Irradiation Is Ineffective in Normalizing Plasma Insulin-Like Growth Factor I in Patients with Acromegaly 1

Ariel Barkan

The Journal of Clinical Endocrinology & Metabolism, 1997

View PDFchevron_right

Inter-relations between growth hormone, insulin, insulin-like growth factor-l (IGF-I), IGF-binding protein-1 (IGFBP-1) and sex hormone-binding globulin in acromegaly

Jeff Holly

Clinical Endocrinology, 1991

View PDFchevron_right

An acromegalic patient with low Insulin-Like Growth Factor-1 levels: it may not be found to be elevated during diagnosis of acromegaly each time

Mithat Bahceci

2015

View PDFchevron_right

Analysis of IGF(CA)19 and IGFBP3-202A/C gene polymorphisms in patients with acromegaly: association with clinical presentation and response to treatments

Ignacio Bernabeu, Ana Ramos-levi

European journal of endocrinology / European Federation of Endocrine Societies, 2015

View PDFchevron_right

Acromegaly Associated with Type 2 Diabetes Showing Normal IGF-1 Levels under Poorly Controlled Glycemia

Bong-yun Cha

Endocrine Journal, 2007

View PDFchevron_right

Insulin-like growth factor-I correlates more closely than growth hormone with insulin resistance and glucose intolerance in patients with acromegaly

Mariana Purice

Pituitary, 2012

View PDFchevron_right

Control of IGF-I levels with titrated dosing of lanreotide Autogel over 48weeks in patients with acromegaly

Françoise Borson-chazot

Clinical Endocrinology, 2008

View PDFchevron_right

Assessment of disease activity in acromegaly by means of a single blood sample: comparison of the 120th minute postglucose value with spontaneous GH secretion and with the IGF system

Diego Barreca

Clinical Endocrinology, 2004

View PDFchevron_right

Discordant GH and IGF-1 Results in Treated Acromegaly: Impact of GH Cutoffs and Mean Values Assessment

Federico Gatto

The Journal of Clinical Endocrinology & Metabolism

View PDFchevron_right

IGF(CA)19 and IGFBP-3-202A/C gene polymorphism in patients with acromegaly

Sebahat Turgut, Fulya Akin

Growth Hormone & IGF Research, 2010

View PDFchevron_right

Igf-I Levels in the Cerebrospinal Fluid in Patients With Acromegaly

Sergiu-Bogdan Catrina

Acta Endocrinologica …, 2008

View PDFchevron_right

Conventional pituitary irradiation is effective in normalising plasma IGF-I in patients with acromegaly

Katherine Morrison

European Journal of Endocrinology, 2001

View PDFchevron_right

Inverse correlation between insulin‐like growth factor binding protein‐I and insulin in patients with acromegaly during treatment with the somatostatin analogue octreotide

jyoti bala

Clinical Endocrinology, 1994

View PDFchevron_right

Comparative study of insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 (IGFBP-3) level and ratio measurements and their relationship with an index of …

R. García-mayor

Metabolism- …, 1997

View PDFchevron_right

Insulin-like Growth Factors in a clinical setting: review of IGF-I

Maurizio Iacobone

Biomedical Papers, 2015

View PDFchevron_right

Alternate-Day Administration of Pegvisomant Maintains Normal Serum Insulin-Like Growth Factor-I Levels in Patients with Acromegaly

CARLOS EDUARDO BELTRAN REYES

The Journal of Clinical Endocrinology & Metabolism, 2005

View PDFchevron_right

Relationship between Disease-Related Morbidity and Biochemical Markers of Activity in Patients with Acromegaly

Kalmon Post

The Journal of Clinical Endocrinology & Metabolism, 2005

View PDFchevron_right

Determinants of Survival in Treated Acromegaly in a Single Center: Predictive Value of Serial Insulin-Like Growth Factor I Measurements

Ferdinand Roelfsema

View PDFchevron_right

The effect of pegvisomant-induced serum IGF-I normalization on serum leptin levels in patients with acromegaly

Andrew Whatmore

Clinical Endocrinology, 2003

View PDFchevron_right

Prevalence of discordant GH and IGF-I levels in acromegalics at diagnosis, after surgical treatment and during treatment with octreotide LAR®

Giselle Taboada

Growth Hormone & IGF Research, 2008

View PDFchevron_right

Targeting either GH or IGF-I during somatostatin analogue treatment in patients with acromegaly: a randomized multicentre study

Ulla Feldt-rasmussen

European Journal of Endocrinology, 2018

View PDFchevron_right